5 Best Stocks Under $10 to Buy Right Now

4. Amneal Pharmaceuticals, Inc. (NYSE: AMRX)

Number of Hedge Fund Holders: 15

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is a developer of generic and specialty pharmaceutical products for several dosage forms and therapeutic areas. It has three segments: Generics, Specialty, and AvKARE. It ranks 4th on our list of the best stocks under $10 to buy right now.

On June 17th, Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced its FDA approval for the Biologics License Application for Bevacizumab to treat metastatic colorectal cancer, in light of which the stock’s shares gained over 8% premarket. In the first quarter of 2021, Amneal Pharmaceuticals, Inc. (NYSE: AMRX) had an EPS of $0.20, beating estimates by $0.02. The company’s revenue was $493.11 million, missing estimates by -$19.58 million. The stock has gained 4.47% in the past 6 months and 5.33% year to date, and it has a forward PE ratio of 6.32. Amneal Pharmaceuticals, Inc. (NYSE: AMRX) has a gross profit margin of 33.04% as well.

By the end of the first quarter of 2021, 15 hedge funds out of the 866 tracked by Insider Monkey held stakes in Amneal Pharmaceuticals, Inc. (NYSE: AMRX). The total value of their stakes was roughly $77.5 million. This is compared to 8 hedge fund holders in the previous quarter with a total stake value of about $17.9 million.